Cargando…
The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Children Aged 5–11 Years — United States, November 2021
| Autores principales: | , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Centers for Disease Control and Prevention
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8580204/ https://www.ncbi.nlm.nih.gov/pubmed/34758012 http://dx.doi.org/10.15585/mmwr.mm7045e1 |
| _version_ | 1784596565131788288 |
|---|---|
| author | Woodworth, Kate R. Moulia, Danielle Collins, Jennifer P. Hadler, Stephen C. Jones, Jefferson M. Reddy, Sujan C. Chamberland, Mary Campos-Outcalt, Doug Morgan, Rebecca L. Brooks, Oliver Talbot, H. Keipp Lee, Grace M. Bell, Beth P. Daley, Matthew F. Mbaeyi, Sarah Dooling, Kathleen Oliver, Sara E. |
| author_facet | Woodworth, Kate R. Moulia, Danielle Collins, Jennifer P. Hadler, Stephen C. Jones, Jefferson M. Reddy, Sujan C. Chamberland, Mary Campos-Outcalt, Doug Morgan, Rebecca L. Brooks, Oliver Talbot, H. Keipp Lee, Grace M. Bell, Beth P. Daley, Matthew F. Mbaeyi, Sarah Dooling, Kathleen Oliver, Sara E. |
| author_sort | Woodworth, Kate R. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8580204 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Centers for Disease Control and Prevention |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-85802042021-11-19 The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Children Aged 5–11 Years — United States, November 2021 Woodworth, Kate R. Moulia, Danielle Collins, Jennifer P. Hadler, Stephen C. Jones, Jefferson M. Reddy, Sujan C. Chamberland, Mary Campos-Outcalt, Doug Morgan, Rebecca L. Brooks, Oliver Talbot, H. Keipp Lee, Grace M. Bell, Beth P. Daley, Matthew F. Mbaeyi, Sarah Dooling, Kathleen Oliver, Sara E. MMWR Morb Mortal Wkly Rep Full Report Centers for Disease Control and Prevention 2021-11-12 /pmc/articles/PMC8580204/ /pubmed/34758012 http://dx.doi.org/10.15585/mmwr.mm7045e1 Text en https://creativecommons.org/publicdomain/zero/1.0/All material in the MMWR Series is in the public domain and may be used and reprinted without permission; citation as to source, however, is appreciated. |
| spellingShingle | Full Report Woodworth, Kate R. Moulia, Danielle Collins, Jennifer P. Hadler, Stephen C. Jones, Jefferson M. Reddy, Sujan C. Chamberland, Mary Campos-Outcalt, Doug Morgan, Rebecca L. Brooks, Oliver Talbot, H. Keipp Lee, Grace M. Bell, Beth P. Daley, Matthew F. Mbaeyi, Sarah Dooling, Kathleen Oliver, Sara E. The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Children Aged 5–11 Years — United States, November 2021 |
| title | The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Children Aged 5–11 Years — United States, November 2021 |
| title_full | The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Children Aged 5–11 Years — United States, November 2021 |
| title_fullStr | The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Children Aged 5–11 Years — United States, November 2021 |
| title_full_unstemmed | The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Children Aged 5–11 Years — United States, November 2021 |
| title_short | The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Children Aged 5–11 Years — United States, November 2021 |
| title_sort | advisory committee on immunization practices’ interim recommendation for use of pfizer-biontech covid-19 vaccine in children aged 5–11 years — united states, november 2021 |
| topic | Full Report |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8580204/ https://www.ncbi.nlm.nih.gov/pubmed/34758012 http://dx.doi.org/10.15585/mmwr.mm7045e1 |
| work_keys_str_mv | AT woodworthkater theadvisorycommitteeonimmunizationpracticesinterimrecommendationforuseofpfizerbiontechcovid19vaccineinchildrenaged511yearsunitedstatesnovember2021 AT mouliadanielle theadvisorycommitteeonimmunizationpracticesinterimrecommendationforuseofpfizerbiontechcovid19vaccineinchildrenaged511yearsunitedstatesnovember2021 AT collinsjenniferp theadvisorycommitteeonimmunizationpracticesinterimrecommendationforuseofpfizerbiontechcovid19vaccineinchildrenaged511yearsunitedstatesnovember2021 AT hadlerstephenc theadvisorycommitteeonimmunizationpracticesinterimrecommendationforuseofpfizerbiontechcovid19vaccineinchildrenaged511yearsunitedstatesnovember2021 AT jonesjeffersonm theadvisorycommitteeonimmunizationpracticesinterimrecommendationforuseofpfizerbiontechcovid19vaccineinchildrenaged511yearsunitedstatesnovember2021 AT reddysujanc theadvisorycommitteeonimmunizationpracticesinterimrecommendationforuseofpfizerbiontechcovid19vaccineinchildrenaged511yearsunitedstatesnovember2021 AT chamberlandmary theadvisorycommitteeonimmunizationpracticesinterimrecommendationforuseofpfizerbiontechcovid19vaccineinchildrenaged511yearsunitedstatesnovember2021 AT camposoutcaltdoug theadvisorycommitteeonimmunizationpracticesinterimrecommendationforuseofpfizerbiontechcovid19vaccineinchildrenaged511yearsunitedstatesnovember2021 AT morganrebeccal theadvisorycommitteeonimmunizationpracticesinterimrecommendationforuseofpfizerbiontechcovid19vaccineinchildrenaged511yearsunitedstatesnovember2021 AT brooksoliver theadvisorycommitteeonimmunizationpracticesinterimrecommendationforuseofpfizerbiontechcovid19vaccineinchildrenaged511yearsunitedstatesnovember2021 AT talbothkeipp theadvisorycommitteeonimmunizationpracticesinterimrecommendationforuseofpfizerbiontechcovid19vaccineinchildrenaged511yearsunitedstatesnovember2021 AT leegracem theadvisorycommitteeonimmunizationpracticesinterimrecommendationforuseofpfizerbiontechcovid19vaccineinchildrenaged511yearsunitedstatesnovember2021 AT bellbethp theadvisorycommitteeonimmunizationpracticesinterimrecommendationforuseofpfizerbiontechcovid19vaccineinchildrenaged511yearsunitedstatesnovember2021 AT daleymatthewf theadvisorycommitteeonimmunizationpracticesinterimrecommendationforuseofpfizerbiontechcovid19vaccineinchildrenaged511yearsunitedstatesnovember2021 AT mbaeyisarah theadvisorycommitteeonimmunizationpracticesinterimrecommendationforuseofpfizerbiontechcovid19vaccineinchildrenaged511yearsunitedstatesnovember2021 AT doolingkathleen theadvisorycommitteeonimmunizationpracticesinterimrecommendationforuseofpfizerbiontechcovid19vaccineinchildrenaged511yearsunitedstatesnovember2021 AT oliversarae theadvisorycommitteeonimmunizationpracticesinterimrecommendationforuseofpfizerbiontechcovid19vaccineinchildrenaged511yearsunitedstatesnovember2021 AT woodworthkater advisorycommitteeonimmunizationpracticesinterimrecommendationforuseofpfizerbiontechcovid19vaccineinchildrenaged511yearsunitedstatesnovember2021 AT mouliadanielle advisorycommitteeonimmunizationpracticesinterimrecommendationforuseofpfizerbiontechcovid19vaccineinchildrenaged511yearsunitedstatesnovember2021 AT collinsjenniferp advisorycommitteeonimmunizationpracticesinterimrecommendationforuseofpfizerbiontechcovid19vaccineinchildrenaged511yearsunitedstatesnovember2021 AT hadlerstephenc advisorycommitteeonimmunizationpracticesinterimrecommendationforuseofpfizerbiontechcovid19vaccineinchildrenaged511yearsunitedstatesnovember2021 AT jonesjeffersonm advisorycommitteeonimmunizationpracticesinterimrecommendationforuseofpfizerbiontechcovid19vaccineinchildrenaged511yearsunitedstatesnovember2021 AT reddysujanc advisorycommitteeonimmunizationpracticesinterimrecommendationforuseofpfizerbiontechcovid19vaccineinchildrenaged511yearsunitedstatesnovember2021 AT chamberlandmary advisorycommitteeonimmunizationpracticesinterimrecommendationforuseofpfizerbiontechcovid19vaccineinchildrenaged511yearsunitedstatesnovember2021 AT camposoutcaltdoug advisorycommitteeonimmunizationpracticesinterimrecommendationforuseofpfizerbiontechcovid19vaccineinchildrenaged511yearsunitedstatesnovember2021 AT morganrebeccal advisorycommitteeonimmunizationpracticesinterimrecommendationforuseofpfizerbiontechcovid19vaccineinchildrenaged511yearsunitedstatesnovember2021 AT brooksoliver advisorycommitteeonimmunizationpracticesinterimrecommendationforuseofpfizerbiontechcovid19vaccineinchildrenaged511yearsunitedstatesnovember2021 AT talbothkeipp advisorycommitteeonimmunizationpracticesinterimrecommendationforuseofpfizerbiontechcovid19vaccineinchildrenaged511yearsunitedstatesnovember2021 AT leegracem advisorycommitteeonimmunizationpracticesinterimrecommendationforuseofpfizerbiontechcovid19vaccineinchildrenaged511yearsunitedstatesnovember2021 AT bellbethp advisorycommitteeonimmunizationpracticesinterimrecommendationforuseofpfizerbiontechcovid19vaccineinchildrenaged511yearsunitedstatesnovember2021 AT daleymatthewf advisorycommitteeonimmunizationpracticesinterimrecommendationforuseofpfizerbiontechcovid19vaccineinchildrenaged511yearsunitedstatesnovember2021 AT mbaeyisarah advisorycommitteeonimmunizationpracticesinterimrecommendationforuseofpfizerbiontechcovid19vaccineinchildrenaged511yearsunitedstatesnovember2021 AT doolingkathleen advisorycommitteeonimmunizationpracticesinterimrecommendationforuseofpfizerbiontechcovid19vaccineinchildrenaged511yearsunitedstatesnovember2021 AT oliversarae advisorycommitteeonimmunizationpracticesinterimrecommendationforuseofpfizerbiontechcovid19vaccineinchildrenaged511yearsunitedstatesnovember2021 |